122 related articles for article (PubMed ID: 34958810)
1. ABCC2 expression in papillary renal cell carcinoma provides better prognostic stratification than WHO/ISUP nucleolar grade.
Saleeb RM; Brimo F; Gao Y; Boulos C; Kim SS; Al Bashir S; Husain A; Rotondo F; Beharry V; Bjarnason GA; Krizova A; Trpkov K; Yousef GM
Hum Pathol; 2022 Feb; 120():57-70. PubMed ID: 34958810
[TBL] [Abstract][Full Text] [Related]
2. Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
Saleeb RM; Plant P; Tawedrous E; Krizova A; Brimo F; Evans AJ; Wala SJ; Bartlett J; Ding Q; Boles D; Rotando F; Farag M; Yousef GM
Eur Urol Focus; 2018 Sep; 4(5):740-748. PubMed ID: 28753789
[TBL] [Abstract][Full Text] [Related]
3. Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis.
Saleeb RM; Brimo F; Farag M; Rompré-Brodeur A; Rotondo F; Beharry V; Wala S; Plant P; Downes MR; Pace K; Evans A; Bjarnason G; Bartlett JMS; Yousef GM
Am J Surg Pathol; 2017 Dec; 41(12):1618-1629. PubMed ID: 28984673
[TBL] [Abstract][Full Text] [Related]
4. ABCC2 brush-border expression predicts outcome in papillary renal cell carcinoma: a multi-institutional study of 254 cases.
Castillo VF; Masoomian M; Trpkov K; Downes M; Brimo F; van der Kwast T; Yousef GM; Zakhary A; Rotondo F; Saad G; Nguyen VN; Kidanewold W; Streutker C; Rowsell C; Hamdani M; Saleeb RM
Histopathology; 2023 Dec; 83(6):949-958. PubMed ID: 37680023
[TBL] [Abstract][Full Text] [Related]
5. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
[TBL] [Abstract][Full Text] [Related]
6. Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy.
Saleeb RM; Farag M; Lichner Z; Brimo F; Bartlett J; Bjarnason G; Finelli A; Rontondo F; Downes MR; Yousef GM
Mol Oncol; 2018 Oct; 12(10):1673-1688. PubMed ID: 29896907
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality.
Mejean A; Hopirtean V; Bazin JP; Larousserie F; Benoit H; Chrétien Y; Thiounn N; Dufour B
J Urol; 2003 Sep; 170(3):764-7. PubMed ID: 12913693
[TBL] [Abstract][Full Text] [Related]
8. High WHO/ISUP Grade and Unfavorable Architecture, Rather Than Typing of Papillary Renal Cell Carcinoma, May Be Associated With Worse Prognosis.
Yang C; Shuch B; Kluger H; Humphrey PA; Adeniran AJ
Am J Surg Pathol; 2020 May; 44(5):582-593. PubMed ID: 32101890
[TBL] [Abstract][Full Text] [Related]
9. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.
Kim SS; Cho YM; Kim GH; Kee KH; Kim HS; Kim KM; Kim JH; Choi C
Mod Pathol; 2020 Apr; 33(4):690-699. PubMed ID: 31953522
[TBL] [Abstract][Full Text] [Related]
10. High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma.
Polifka I; Agaimy A; Herrmann E; Spath V; Trojan L; Stöckle M; Becker F; Ströbel P; Wülfing C; Schrader AJ; Barth P; Staehler M; Stief C; Hohenfellner M; Macher-Göppinger S; Wullich B; Noldus J; Brenner W; Roos FC; Walter B; Otto W; Burger M; Höfler H; Haferkamp A; Geppert CI; Stöhr C; Hartmann A;
Hum Pathol; 2019 Jan; 83():212-223. PubMed ID: 30121370
[TBL] [Abstract][Full Text] [Related]
11. Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases.
Marsaud A; Dadone B; Ambrosetti D; Baudoin C; Chamorey E; Rouleau E; Lefol C; Roussel JF; Fabas T; Cristofari G; Carpentier X; Michiels JF; Amiel J; Pedeutour F
Genes Chromosomes Cancer; 2015 Jun; 54(6):369-82. PubMed ID: 25820192
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinicopathologic parameters and oncologic outcomes between type 1 and type 2 papillary renal cell carcinoma.
Le X; Wang XB; Zhao H; Chen RF; Ge P
BMC Urol; 2020 Sep; 20(1):148. PubMed ID: 32933514
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma.
Wang Y; Tian X; Zhu SX; Xu WH; Anwaier A; Su JQ; Gan HL; Qu YY; Zhao JY; Zhang HL; Ye DW
World J Surg Oncol; 2023 Mar; 21(1):98. PubMed ID: 36927438
[TBL] [Abstract][Full Text] [Related]
14. Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarity.
Kiyozawa D; Kohashi K; Takamatsu D; Yamamoto T; Eto M; Iwasaki T; Motoshita J; Shimokama T; Kinjo M; Oshiro Y; Yonemasu H; Oda Y
Hum Pathol; 2021 Jun; 112():48-58. PubMed ID: 33811832
[TBL] [Abstract][Full Text] [Related]
15. Papillary renal neoplasm with reverse polarity is biologically and clinically distinct from eosinophilic papillary renal cell carcinoma.
Castillo VF; Trpkov K; Van der Kwast T; Rotondo F; Hamdani M; Saleeb R
Pathol Int; 2024 Apr; 74(4):222-226. PubMed ID: 38456605
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for the survival of patients with papillary renal cell carcinoma after surgical management.
Ren W; Gao X; Zhang X; Hu J; Li H; Zu X
Clin Transl Oncol; 2020 May; 22(5):725-733. PubMed ID: 31317521
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of gene expression and integrin-associated signaling pathways in papillary renal cell carcinoma subtypes.
Zhang K; Lee HM; Wei GH; Manninen A
Oncotarget; 2016 Dec; 7(51):84178-84189. PubMed ID: 27705936
[TBL] [Abstract][Full Text] [Related]
19. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
[TBL] [Abstract][Full Text] [Related]
20. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases.
Han G; Yu W; Chu J; Liu Y; Jiang Y; Li Y; Zhang W
Pathol Res Pract; 2017 Jan; 213(1):1-6. PubMed ID: 27931799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]